HIV Infection Clinical Trials

171 recruitingLast updated: July 16, 2026

There are 171 actively recruiting hiv infection clinical trials across 49 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3. Top locations include New York, New York, United States, San Francisco, California, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


HIV Infection Trials at a Glance

171 actively recruiting trials for hiv infection are listed on ClinicalTrialsFinder across 6 cities in 49 countries. The largest study group is Not Applicable with 76 trials, with the heaviest enrollment activity in New York, San Francisco, and Houston. Lead sponsors running hiv infection studies include ViiV Healthcare, University of California, San Francisco, and Columbia University.

Browse hiv infection trials by phase

Treatments under study

About HIV Infection Clinical Trials

Looking for clinical trials for HIV Infection? There are currently 27 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HIV Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HIV Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 171 trials

Recruiting
Phase 2

Colchicine to Reduce Coronary Artery Inflammation in People With HIV

HIV InfectionCardiovascular Diseases (CVD)
Instituto de Investigación Hospital Universitario La Paz90 enrolled4 locationsNCT07704164
Recruiting
Phase 1Phase 2

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID)1,120 enrolled46 locationsNCT02140255
Recruiting
Phase 1

A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants

HIV Infections
ViiV Healthcare214 enrolled1 locationNCT07525544
Recruiting
Phase 1

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

HIV InfectionRecurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+12 more
AIDS Malignancy Consortium20 enrolled7 locationsNCT05077527
Recruiting
Phase 3

Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT

HIV Infections
Africa Health Research Institute2,052 enrolled1 locationNCT06250504
Recruiting
Not Applicable

Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys

HIV Infections
Center for Innovative Public Health Research5,000 enrolled2 locationsNCT06230367
Recruiting
Phase 1

Dasatinib for HIV-1 Reservoir Reduction

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)14 enrolled3 locationsNCT07342491
Recruiting
Not Applicable

Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

HIV Infections
Boston University266 enrolled2 locationsNCT06088277
Recruiting
Phase 1

First Time in Human Study of Long Acting VH4524184 Formulations

HIV Infections
ViiV Healthcare372 enrolled3 locationsNCT06310551
Recruiting
Phase 1

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

HIV Infections
ViiV Healthcare9 enrolled1 locationNCT07636928
Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

HIV Infections
Gilead Sciences3,000 enrolled28 locationsNCT07473778
Recruiting
Phase 4

Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up

HIV InfectionAntiretroviral TherapyLentivirus Infections
Instituto Mexicano del Seguro Social78 enrolled1 locationNCT07678268
Recruiting
Not Applicable

Integrated Navigation Services for Treatment Adherence, Counseling, and Research

HIV Infection Primary
University of Miami10 enrolled1 locationNCT04663152
Recruiting

Dental Management of Patients With HIV in Pays de la Loire

HIV InfectionOral Health CareAcquired Immune Deficiency Syndrome
Nantes University Hospital5,603 enrolled1 locationNCT07552038
Recruiting
Not Applicable

An Effectiveness Trial of the PrEP for WINGS Study

HIV InfectionsAlcohol Use DisorderViolence, Gender-Based
Columbia University307 enrolled1 locationNCT06853314
Recruiting

People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

HIV InfectionsOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
University of California, San Francisco144 enrolled1 locationNCT06055868
Recruiting
Not Applicable

Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People

HIV InfectionsSubstance Use Disorders
Medical University of South Carolina50 enrolled1 locationNCT05816083
Recruiting
Not Applicable

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

HIV InfectionTobacco-Related Carcinoma
AIDS Malignancy Consortium100 enrolled11 locationsNCT04949464
Recruiting

Skeletal Muscle Energetics and Fatiguability in Older Individuals

HIV InfectionsHIV
Johns Hopkins University200 enrolled1 locationNCT04142047
Recruiting
Phase 1

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706

HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)40 enrolled9 locationsNCT06665646